Zotefoams (ZTF) Competitors

GBX 377 -5.00 (-1.31%)

As of 05/18/2026 12:21 PM Eastern

ZTF vs. VCT, SCPA, ESNT, TET, and SYNT

Should you buy Zotefoams stock or one of its competitors? MarketBeat compares Zotefoams with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zotefoams include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), and Synthomer (SYNT). These companies are all part of the "specialty chemicals" industry.

How does Zotefoams compare to Victrex?

Victrex (LON:VCT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Zotefoams has a net margin of 14.28% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.25% beat Victrex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Victrex	-6.70%	-4.95%	6.59%
Zotefoams	14.28%	18.25%	5.48%

Victrex currently has a consensus target price of GBX 702.86, suggesting a potential upside of 16.28%. Zotefoams has a consensus target price of GBX 605, suggesting a potential upside of 60.48%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts plainly believe Zotefoams is more favorable than Victrex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Victrex	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Victrex pays an annual dividend of GBX 59.56 per share and has a dividend yield of 9.9%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 2.0%. Victrex pays out 187.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Zotefoams pays out 16.9% of its earnings in the form of a dividend.

Victrex has higher revenue and earnings than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Victrex	£296.40M	1.78	£30.80M	£31.80	19.01
Zotefoams	£158.49M	1.16	£9.80M	£44.87	8.40

In the previous week, Victrex had 3 more articles in the media than Zotefoams. MarketBeat recorded 5 mentions for Victrex and 2 mentions for Zotefoams. Zotefoams' average media sentiment score of 0.00 beat Victrex's score of -0.03 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Victrex	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zotefoams	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Victrex has a beta of 0.751, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market.

75.5% of Victrex shares are owned by institutional investors. Comparatively, 29.5% of Zotefoams shares are owned by institutional investors. 4.2% of Victrex shares are owned by insiders. Comparatively, 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Zotefoams beats Victrex on 10 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Scapa Group?

Scapa Group (LON:SCPA) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Zotefoams has a net margin of 14.28% compared to Scapa Group's net margin of 0.00%. Zotefoams' return on equity of 18.25% beat Scapa Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scapa Group	N/A	N/A	N/A
Zotefoams	14.28%	18.25%	5.48%

In the previous week, Zotefoams had 2 more articles in the media than Scapa Group. MarketBeat recorded 2 mentions for Zotefoams and 0 mentions for Scapa Group. Scapa Group's average media sentiment score of 0.00 equaled Zotefoams'average media sentiment score.

Company	Overall Sentiment
Scapa Group	Neutral
Zotefoams	Neutral

Zotefoams has lower revenue, but higher earnings than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A
Zotefoams	£158.49M	1.16	£9.80M	£44.87	8.40

29.5% of Zotefoams shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 60.48%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts clearly believe Zotefoams is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Zotefoams beats Scapa Group on 11 of the 12 factors compared between the two stocks.

How does Zotefoams compare to Essentra?

Essentra (LON:ESNT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Zotefoams has a net margin of 14.28% compared to Essentra's net margin of 0.70%. Zotefoams' return on equity of 18.25% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essentra	0.70%	0.79%	1.74%
Zotefoams	14.28%	18.25%	5.48%

Essentra has a beta of 0.802, indicating that its share price is 20% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.255, indicating that its share price is 26% more volatile than the broader market.

Essentra pays an annual dividend of GBX 2.35 per share and has a dividend yield of 2.9%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 2.0%. Essentra pays out 335.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Zotefoams pays out 16.9% of its earnings in the form of a dividend.

Essentra currently has a consensus price target of GBX 150, indicating a potential upside of 84.05%. Zotefoams has a consensus price target of GBX 605, indicating a potential upside of 60.48%. Given Essentra's higher probable upside, equities analysts clearly believe Essentra is more favorable than Zotefoams.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Zotefoams had 1 more articles in the media than Essentra. MarketBeat recorded 2 mentions for Zotefoams and 1 mentions for Essentra. Essentra's average media sentiment score of 0.00 equaled Zotefoams'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Essentra	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zotefoams	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

69.5% of Essentra shares are owned by institutional investors. Comparatively, 29.5% of Zotefoams shares are owned by institutional investors. 0.5% of Essentra shares are owned by company insiders. Comparatively, 4.5% of Zotefoams shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Zotefoams has lower revenue, but higher earnings than Essentra. Zotefoams is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essentra	£302M	0.77	£3.50M	£0.70	116.43
Zotefoams	£158.49M	1.16	£9.80M	£44.87	8.40

Summary

Zotefoams beats Essentra on 11 of the 17 factors compared between the two stocks.

How does Zotefoams compare to Treatt?

Treatt (LON:TET) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Zotefoams had 1 more articles in the media than Treatt. MarketBeat recorded 2 mentions for Zotefoams and 1 mentions for Treatt. Treatt's average media sentiment score of 0.75 beat Zotefoams' score of 0.00 indicating that Treatt is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treatt	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zotefoams	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treatt pays an annual dividend of GBX 5.60 per share and has a dividend yield of 1.9%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 2.0%. Treatt pays out 77.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Zotefoams is clearly the better dividend stock, given its higher yield and lower payout ratio.

Zotefoams has a net margin of 14.28% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.25% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Zotefoams	14.28%	18.25%	5.48%

Treatt presently has a consensus target price of GBX 248.33, indicating a potential downside of 17.36%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 60.48%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts clearly believe Zotefoams is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

17.4% of Treatt shares are held by institutional investors. Comparatively, 29.5% of Zotefoams shares are held by institutional investors. 4.1% of Treatt shares are held by insiders. Comparatively, 4.5% of Zotefoams shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Treatt has higher earnings, but lower revenue than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.38	£11.22M	£7.22	41.62
Zotefoams	£158.49M	1.16	£9.80M	£44.87	8.40

Treatt has a beta of 0.677, meaning that its share price is 32% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.255, meaning that its share price is 26% more volatile than the broader market.

Summary

Zotefoams beats Treatt on 13 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Synthomer?

Zotefoams (LON:ZTF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

In the previous week, Zotefoams had 1 more articles in the media than Synthomer. MarketBeat recorded 2 mentions for Zotefoams and 1 mentions for Synthomer. Zotefoams' average media sentiment score of 0.00 equaled Synthomer'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zotefoams	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Synthomer	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zotefoams has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.16	£9.80M	£44.87	8.40
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A

Zotefoams presently has a consensus price target of GBX 605, indicating a potential upside of 60.48%. Synthomer has a consensus price target of GBX 86.75, indicating a potential downside of 17.94%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts clearly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

29.5% of Zotefoams shares are owned by institutional investors. Comparatively, 19.9% of Synthomer shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by company insiders. Comparatively, 5.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Synthomer	-9.03%	-16.66%	-0.28%

Zotefoams has a beta of 1.255, meaning that its share price is 26% more volatile than the broader market. Comparatively, Synthomer has a beta of 0.922, meaning that its share price is 8% less volatile than the broader market.

Summary

Zotefoams beats Synthomer on 13 of the 15 factors compared between the two stocks.

Get Zotefoams News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZTF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZTF vs. The Competition

Export

Metric	Zotefoams	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£184.44M	£8.23B	£4.78B	£2.76B
Dividend Yield	2.06%	3.43%	5.00%	6.15%
P/E Ratio	8.40	17.52	22.99	365.85
Price / Sales	1.16	111.03	7,478.60	88,116.32
Price / Cash	18.87	19.25	24.32	27.89
Price / Book	1.53	3.23	6.87	7.62
Net Income	£9.80M	£213.62M	£157.11M	£5.89B
7 Day Performance	-4.07%	1.12%	-2.64%	0.41%
1 Month Performance	-1.95%	7.29%	-1.47%	0.55%
1 Year Performance	41.73%	30.05%	79.60%	84.40%

Zotefoams Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZTF Zotefoams	3.8987 of 5 stars	GBX 377 -1.3%	GBX 605 +60.5%	+39.6%	£184.44M	£158.49M	8.40	549
VCT Victrex	2.3939 of 5 stars	GBX 594.95 +1.7%	GBX 702.86 +18.1%	-26.4%	£518.35M	£296.40M	18.71	1,109	Earnings Report Analyst Downgrade
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	3.5008 of 5 stars	GBX 82 -0.7%	GBX 150 +82.9%	-17.7%	£232.81M	£302M	117.14	350
TET Treatt	1.0074 of 5 stars	GBX 299 flat	GBX 248.33 -16.9%	+16.9%	£176.52M	£128.29M	41.41	350

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:ZTF) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zotefoams (ZTF) Competitors